| 1 | PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs | 2.6 | 3 | Citations (PDF) |
| 2 | A call for compassionate opioid overdose response | 3.4 | 22 | Citations (PDF) |
| 3 | The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses | 1.9 | 27 | Citations (PDF) |
| 4 | Perspectives and recommendations of opioid overdose survivors experiencing unsheltered homelessness on housing, overdose, and substance use treatment in Boston, MA | 3.4 | 17 | Citations (PDF) |
| 5 | The police paradox: A qualitative study of post-overdose outreach program implementation through public health-public safety partnerships in Massachusetts | 3.4 | 19 | Citations (PDF) |
| 6 | Pharmacists’ experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study | 1.8 | 11 | Citations (PDF) |
| 7 | Predicting longitudinal service use for individuals with substance use disorders: A latent profile analysis | 2.7 | 15 | Citations (PDF) |
| 8 | Warrant checking practices by post-overdose outreach programs in Massachusetts: A mixed-methods study | 3.4 | 22 | Citations (PDF) |
| 9 | “No home to take methadone to”: Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston | 2.7 | 28 | Citations (PDF) |
| 10 | Broadening access to naloxone: Community predictors of standing order naloxone distribution in Massachusetts | 3.0 | 22 | Citations (PDF) |
| 11 | Limited access to pharmacy-based naloxone in West Virginia: Results from a statewide purchase trial | 3.0 | 10 | Citations (PDF) |
| 12 | A collaborative care intervention to improve opioid prescribing among providers caring for persons with HIV: Impact on satisfaction, confidence, and trust | 3.0 | 3 | Citations (PDF) |
| 13 | Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design | 1.8 | 28 | Citations (PDF) |
| 14 | Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study | 19.5 | 99 | Citations (PDF) |
| 15 | Northeast Postacute Medical Facilities Disproportionately Reject Referrals For Patients With Opioid Use Disorder | 5.6 | 22 | Citations (PDF) |
| 16 | If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study | 3.3 | 6 | Citations (PDF) |
| 17 | Prescribe to Save Lives: Improving Buprenorphine Prescribing Among HIV Clinicians | 1.8 | 6 | Citations (PDF) |
| 18 | Functional Impairment and Cognitive Symptoms Among People with HIV Infection on Chronic Opioid Therapy for Pain: The Impact of Gabapentin and Other Sedating Medications | 2.0 | 2 | Citations (PDF) |
| 19 | “There’s No Heroin Around Anymore. It’s All Fentanyl.” Adaptation of an Opioid Overdose Prevention Counseling Approach to Address Fentanyl Overdose: Formative Study | 2.0 | 16 | Citations (PDF) |
| 20 | Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial | 5.4 | 22 | Citations (PDF) |
| 21 | Against Medical Advice Discharges in Injection and Non-injection Drug Use-associated Infective Endocarditis: A Nationwide Cohort Study | 5.4 | 46 | Citations (PDF) |
| 22 | Predictors of pain-related functional impairment among people living with HIV on long-term opioid therapy | 1.5 | 18 | Citations (PDF) |
| 23 | Emergency Department Utilization Among People Living With HIV on Chronic Opioid Therapy | 1.7 | 1 | Citations (PDF) |
| 24 | Characteristics of post-overdose public health-public safety outreach in Massachusetts | 3.0 | 26 | Citations (PDF) |
| 25 | Projected Estimates of Opioid Mortality After Community-Level Interventions | 6.9 | 64 | Citations (PDF) |
| 26 | Competing risks of women and men who use fentanyl: “The number one thing I worry about would be my safety and number two would be overdose” | 2.7 | 24 | Citations (PDF) |
| 27 | Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge | 3.0 | 28 | Citations (PDF) |
| 28 | Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort | 3.0 | 55 | Citations (PDF) |
| 29 | Integrating substance use care into primary care for adolescents and young adults: Lessons learned | 2.7 | 14 | Citations (PDF) |
| 30 | Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island | 3.4 | 26 | Citations (PDF) |
| 31 | “It could potentially be dangerous... but nothing else has seemed to help me.”: Patient and clinician perspectives on benzodiazepine use in opioid agonist treatment | 2.7 | 10 | Citations (PDF) |
| 32 | Outcomes of Ottawa, Canada's Managed Opioid Program (MOP) where supervised injectable hydromorphone was paired with assisted housing | 3.4 | 15 | Citations (PDF) |
| 33 | Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts | 2.0 | 60 | Citations (PDF) |
| 34 | Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy | 2.5 | 2 | Citations (PDF) |
| 35 | Effect of Publicly Reported Aortic Valve Surgery Outcomes on Valve Surgery in Injection Drug– and Non–Injection Drug–Associated Endocarditis | 5.4 | 10 | Citations (PDF) |
| 36 | Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy | 3.4 | 28 | Citations (PDF) |
| 37 | Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose | 1.1 | 35 | Citations (PDF) |
| 38 | Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study | 1.8 | 12 | Citations (PDF) |
| 39 | The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study | 3.0 | 108 | Citations (PDF) |
| 40 | Assessing pharmacy-based naloxone access using an innovative purchase trial methodology | 1.8 | 20 | Citations (PDF) |
| 41 | Buprenorphine waiver uptake among nurse practitioners and physician assistants: The role of existing waivered prescriber supply | 2.7 | 28 | Citations (PDF) |
| 42 | Inpatient addiction consultation and post-discharge 30-day acute care utilization | 3.0 | 30 | Citations (PDF) |
| 43 | Opioid overdose and inpatient care for substance use disorder care in Massachusetts | 2.7 | 24 | Citations (PDF) |
| 44 | The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices | 3.0 | 112 | Citations (PDF) |
| 45 | Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches | 1.8 | 19 | Citations (PDF) |
| 46 | Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use–Associated Infective Endocarditis | 6.9 | 91 | Citations (PDF) |
| 47 | Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review | 3.1 | 13 | Citations (PDF) |
| 48 | Alcohol and Bone Turnover Markers among People Living with HIV and Substance Use Disorder | 2.6 | 7 | Citations (PDF) |
| 49 | Pharmacy leaders’ beliefs about how pharmacies can support a sustainable approach to providing naloxone to the community | 2.1 | 14 | Citations (PDF) |
| 50 | Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting | 6.9 | 32 | Citations (PDF) |
| 51 | Chronic Opioid Therapy in People Living With Human Immunodeficiency Virus: Patients’ Perspectives on Risks, Monitoring, and Guidelines | 5.4 | 21 | Citations (PDF) |
| 52 | Study protocol for the targeting effective analgesia in clinics for HIV (TEACH) study – a cluster randomized controlled trial and parallel cohort to increase guideline concordant care for long-term opioid therapy among people living with HIV | 0.9 | 19 | Citations (PDF) |
| 53 | Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians | 1.8 | 19 | Citations (PDF) |
| 54 | The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015 | 2.2 | 31 | Citations (PDF) |
| 55 | A scoping review of post opioid-overdose interventions | 2.9 | 83 | Citations (PDF) |
| 56 | Touchpoints – Opportunities to predict and prevent opioid overdose: A cohort study | 3.0 | 164 | Citations (PDF) |
| 57 | Which patients receive an addiction consult? A preliminary analysis of the INREACH (INpatient REadmission post-Addiction Consult Help) study | 2.7 | 17 | Citations (PDF) |
| 58 | Factors associated with help seeking by community responders trained in overdose prevention and naloxone administration in Massachusetts | 3.0 | 23 | Citations (PDF) |
| 59 | Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths | 3.0 | 130 | Citations (PDF) |
| 60 | Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort | 3.0 | 149 | Citations (PDF) |
| 61 | Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose | 3.2 | 47 | Citations (PDF) |
| 62 | Opioid overdose deaths and potentially inappropriate opioid prescribing practices (PIP): A spatial epidemiological study | 3.4 | 52 | Citations (PDF) |
| 63 | Standard Fixed-Schedule Methadone Taper Versus Symptom-Triggered Methadone Approach for Treatment of Neonatal Opioid Withdrawal Syndrome | 1.5 | 14 | Citations (PDF) |
| 64 | Marijuana Use and Its Associations With Pain, Opioid Dose, and HIV Viral Suppression Among Persons Living With HIV on Chronic Opioid Therapy | 1.8 | 15 | Citations (PDF) |
| 65 | A strengths-based case management intervention to link HIV-positive people who inject drugs in Russia to HIV careAids, 2019, 33, 1467-1476 | 2.5 | 21 | Citations (PDF) |
| 66 | Provider opioid prescribing practices and the belief that opioids keep people living with HIV engaged in care: a cross-sectional study | 1.5 | 13 | Citations (PDF) |
| 67 | Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012–2014 | 3.0 | 34 | Citations (PDF) |
| 68 | SUN-540 No Effect Of Alcohol Use On Bone Microarchitecture Of The Distal Radius Among HIV Infected Adults | 0.2 | 0 | Citations (PDF) |
| 69 | Post opioid overdose outreach by public health and public safety agencies: Exploration of emerging programs in Massachusetts | 3.4 | 83 | Citations (PDF) |
| 70 | Expanding access to naloxone for family members: The Massachusetts experience | 2.1 | 38 | Citations (PDF) |
| 71 | Massachusetts Health Reform's Effect on Hospitalizations with Substance Use Disorder–Related Diagnoses | 2.2 | 3 | Citations (PDF) |
| 72 | Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population | 2.7 | 300 | Citations (PDF) |
| 73 | Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence | 1.5 | 29 | Citations (PDF) |
| 74 | Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts | 1.5 | 292 | Citations (PDF) |
| 75 | Opioid and cocaine use among primary care patients on buprenorphine—Self-report and urine drug tests | 3.0 | 14 | Citations (PDF) |
| 76 | Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011–2015: A Capture–Recapture Analysis | 2.9 | 143 | Citations (PDF) |
| 77 | Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality | 10.5 | 968 | Citations (PDF) |
| 78 | Alcohol Consumption and Bone Mineral Density in People with HIV and Substance Use Disorder: A Prospective Cohort Study | 2.6 | 17 | Citations (PDF) |
| 79 | Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011–2015 | 3.1 | 59 | Citations (PDF) |
| 80 | Opioid overdose prevention and naloxone rescue kits: what we know and what we don’t know | 2.6 | 144 | Citations (PDF) |
| 81 | Identification of non-steroidal anti-inflammatory drug use disorder: A case report | 3.3 | 15 | Citations (PDF) |
| 82 | Addiction consultation services – Linking hospitalized patients to outpatient addiction treatment | 2.7 | 215 | Citations (PDF) |
| 83 | HIV-infected individuals who use alcohol and other drugs, and virologic suppression | 1.5 | 46 | Citations (PDF) |
| 84 | HIV Stigma and Substance Use Among HIV-Positive Russians with Risky Drinking | 2.0 | 13 | Citations (PDF) |
| 85 | Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs | 3.4 | 6 | Citations (PDF) |
| 86 | Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence | 2.7 | 15 | Citations (PDF) |
| 87 | Characteristics of Fentanyl Overdose — Massachusetts, 2014–2016 | 11.8 | 273 | Citations (PDF) |
| 88 | Sexual violence from police and HIV risk behaviours among HIV‐positive women who inject drugs in St. Petersburg, Russia – a mixed methods study | 3.6 | 23 | Citations (PDF) |
| 89 | Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment | 1.1 | 61 | Citations (PDF) |
| 90 | Mortality in HIV-Infected Alcohol and Drug Users in St. Petersburg, Russia | 2.4 | 13 | Citations (PDF) |
| 91 | Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist | 1.8 | 32 | Citations (PDF) |
| 92 | Comments on Strang<i>et al</i>. (2016): ‘Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?’ | 5.4 | 1 | Citations (PDF) |
| 93 | Identifying Patients for Overdose Prevention With ICD-9 Classification in the Emergency Department, Massachusetts, 2013-2014 | 2.2 | 24 | Citations (PDF) |
| 94 | Lessons Learned from the Expansion of Naloxone Access in Massachusetts and North Carolina | 0.7 | 22 | Citations (PDF) |
| 95 | Orienting patients to greater opioid safety: models of community pharmacy-based naloxone | 3.3 | 99 | Citations (PDF) |
| 96 | Opioid Education and Nasal Naloxone Rescue Kits in the Emergency Department | 0.8 | 136 | Citations (PDF) |
| 97 | Engagement and Substance Dependence in a Primary Care-Based Addiction Treatment Program for People Infected with HIV and People at High-Risk for HIV Infection | 2.7 | 42 | Citations (PDF) |
| 98 | A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming into Clinical Practice | 2.5 | 164 | Citations (PDF) |
| 99 | HIV prevention and treatment strategies can help address the overdose crisis | 2.9 | 4 | Citations (PDF) |
| 100 | Punitive policing and associated substance use risks among HIV‐positive people in Russia who inject drugs | 3.6 | 37 | Citations (PDF) |
| 101 | Patient Perspectives of an Integrated Program of Medical Care and Substance Use Treatment | 2.8 | 74 | Citations (PDF) |
| 102 | Prenatal Buprenorphine Versus Methadone Exposure and Neonatal Outcomes: Systematic Review and Meta-Analysis | 3.4 | 157 | Citations (PDF) |
| 103 | Emergency Medical Services Naloxone Access: A National Systematic Legal Review | 1.7 | 80 | Citations (PDF) |
| 104 | Development and Implementation of an Opioid Overdose Prevention Program Within a Preexisting Substance Use Disorders Treatment Center | 2.0 | 8 | Citations (PDF) |
| 105 | Postpartum changes in methadone maintenance dose | 2.7 | 18 | Citations (PDF) |
| 106 | Risk factors for recent nonfatal overdose among HIV-infected Russians who inject drugs | 1.5 | 12 | Citations (PDF) |
| 107 | Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study | 3.3 | 143 | Citations (PDF) |
| 108 | Expanded Access to Naloxone Among Firefighters, Police Officers, and Emergency Medical Technicians in Massachusetts | 2.9 | 135 | Citations (PDF) |
| 109 | Heroin Use and HIV Disease Progression: Results from a Pilot Study of a Russian Cohort | 2.0 | 9 | Citations (PDF) |
| 110 | 2012 Update in addiction medicine for the generalist | 2.6 | 4 | Citations (PDF) |
| 111 | 2013 Update in addiction medicine for the generalist | 2.6 | 4 | Citations (PDF) |
| 112 | Opioid overdose prevention with intranasal naloxone among people who take methadone | 2.7 | 96 | Citations (PDF) |
| 113 | Is cannabis use associated with HIV drug and sex risk behaviors among Russian HIV-infected risky drinkers? | 3.0 | 21 | Citations (PDF) |
| 114 | Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis | 0.2 | 849 | Citations (PDF) |
| 115 | Methadone Dose, Take Home Status, and Hospital Admission Among Methadone Maintenance Patients | 2.0 | 39 | Citations (PDF) |
| 116 | Acute Care Hospital Utilization Among Medical Inpatients Discharged With a Substance Use Disorder Diagnosis | 2.0 | 139 | Citations (PDF) |
| 117 | Integration of substance use treatment and medical care: A special issue of JSAT | 2.7 | 10 | Citations (PDF) |
| 118 | Nondisclosure of HIV Infection to Sex Partners and Alcohol’s Role: A Russian Experience | 2.0 | 21 | Citations (PDF) |
| 119 | Update in Addiction Medicine for the Generalist | 3.1 | 7 | Citations (PDF) |
| 120 | Are Opioid Dependence and Methadone Maintenance Treatment (MMT) Documented in the Medical Record? A Patient Safety Issue | 3.1 | 16 | Citations (PDF) |
| 121 | The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men | 3.0 | 57 | Citations (PDF) |
| 122 | Saved by the Nose: Bystander-Administered Intranasal Naloxone Hydrochloride for Opioid Overdose | 2.9 | 224 | Citations (PDF) |
| 123 | Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and Barriers | 3.1 | 201 | Citations (PDF) |
| 124 | [Commentary] CAN ONE BE AN EXPERT IN ADDICTION MEDICINE WITHOUT EXPERTISE IN PAIN MANAGEMENT? | 5.4 | 4 | Citations (PDF) |
| 125 | The Patients in Recovery (PIR) Perspective: Teaching Physicians about Methamphetamine | 2.5 | 2 | Citations (PDF) |
| 126 | Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems | 2.5 | 43 | Citations (PDF) |
| 127 | Implications of Cannabis Use and Heavy Alcohol Use on HIV Drug Risk Behaviors in Russian Heroin Users | 2.0 | 12 | Citations (PDF) |
| 128 | Knowledge of and interest in hepatitis C treatment at a methadone clinic | 2.7 | 72 | Citations (PDF) |
| 129 | Title is missing! | 1.9 | 10 | Citations (PDF) |
